Diverse changes in albuminuria during treatment of essential hypertensives with an angiotensin-converting enzyme inhibitor or a calcium channel blocker

被引：0
|
作者：
Lasaridis, A [1 ]
Kopras, A [1 ]
Zebekakis, P [1 ]
Sarafidis, P [1 ]
Metallidis, S [1 ]
Tziolas, I [1 ]
Hatzistavri, L [1 ]
Diamantopoulos, A [1 ]
Kevrekidou, A [1 ]
机构：
[1] Univ Hosp, AHEPA, Thessaloniki, Greece
来源：
JOURNAL OF HYPERTENSION | 2003年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S290 / S290
页数：1
相关论文
共 50 条
  • [1] The regression of vascular changes in hypertension - calcium channel blocker or angiotensin-converting enzyme inhibitor?
    Czarnecka, Danuta
    Styczkiewicz, Katarzyna
    ARTERIAL HYPERTENSION, 2005, 9 (06): : 489 - 498
  • [2] Efficacy of combination therapy with angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertension
    Redon, Josep
    Trenkwalder, Peter R. A.
    Barrios, Vivencio
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (02) : 155 - 164
  • [3] TREATMENT STRATEGIES AND ADHERENCE TO THE TRIPLE COMBINATION OF AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR, A CALCIUM-CHANNEL BLOCKER, AND A DIURETIC
    Rea, Federico
    Morabito, Gabriella
    Savare, Laura
    Pathak, Atul
    Corrao, Giovanni
    Mancia, Giuseppe
    JOURNAL OF HYPERTENSION, 2023, 41 : E80 - E80
  • [4] Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hypertensive US Adults With Albuminuria
    Chu, Chi D.
    Powe, Neil R.
    McCulloch, Charles E.
    Banerjee, Tanushree
    Crews, Deidra C.
    Saran, Rajiv
    Bragg-Gresham, Jennifer
    Morgenstern, Hal
    Pavkov, Meda E.
    Saydah, Sharon H.
    Tuot, Delphine S.
    HYPERTENSION, 2021, 77 (01) : 94 - 102
  • [5] Economic impact of selected fixed combination angiotensin-converting enzyme inhibitor/calcium channel blocker anti-hypertensives among patients with diabetes
    Joyce, AT
    Pedan, A
    Girase, PS
    Rucker, MB
    Ollendorf, D
    VALUE IN HEALTH, 2003, 6 (06) : 665 - 665
  • [6] INTERNATIONAL COMPARISON OF COSTS ASSOCIATED WITH TREATMENT OF HYPERTENSION WITH A CALCIUM CHANNEL BLOCKER AND AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN THE USA AND JAPAN
    Sakamaki, Yusuke
    Sasamura, Hiroyuki
    Ikeda, Shunya
    Saruta, Takao
    NEPHROLOGY, 2005, 10 : A113 - A113
  • [7] Comparison of Health Costs Associated with Treatment of Hypertension with a Calcium Channel Blocker and Angiotensin-Converting Enzyme Inhibitor in the United States and Japan
    Yusuke Sakamaki
    Hiroyuki Sasamura
    Shunya Ikeda
    Naoki Ikegami
    Takao Saruta
    Hypertension Research, 2006, 29 : 333 - 338
  • [8] Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan
    Sakamaki, Yusuke
    Sasamura, Hiroyuki
    Ikeda, Shunya
    HYPERTENSION RESEARCH, 2006, 29 (05) : 333 - 338
  • [9] Fixed low-dose combination of an angiotensin converting enzyme inhibitor and a calcium channel blocker drug in the treatment of essential hypertension
    deLeeuw, PW
    Kroon, AA
    JOURNAL OF HYPERTENSION, 1997, 15 : S39 - S42
  • [10] Advantages of combination therapy of hypertension with calcium channel blocker and angiotensin-converting enzyme inhibitor in patients with impaired renal function
    Dzhaiani, N. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2014, 10 (02) : 238 - 244
12345